Literature DB >> 16494850

Hydroxyl radical scavenging reactivity of proton pump inhibitors.

Wolfgang Alexander Simon1, Ernst Sturm, Hans-Jürgen Hartmann, Ulrich Weser.   

Abstract

In addition to the established control of acid secretion of the class of proton pump inhibitors (PPI) reactivity from the pyridyl methyl sulphinyl benzimidazole type a second independent anti-inflammatory reactivity was observed in vitro. This inhibitory reactivity was clearly noticed using three different assays where the aggressive hydroxyl radicals were successfully trapped in a concentration dependent manner. There is unequivocal evidence that the proton pump inhibitors having the sulphoxide group are able to scavenge hydroxyl radicals which are generated during a Fenton reaction. By way of contrast, the corresponding thioethers were substantially less active. No detectable effect was seen in the superoxide radical scavenging system. In conclusion, pantoprazole as well as the other proton pump inhibitors have a pronounced inhibitory reactivity towards hydroxyl radicals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16494850     DOI: 10.1016/j.bcp.2006.01.009

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  17 in total

Review 1.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

2.  Topical Esomeprazole Mitigates Radiation-Induced Dermal Inflammation and Fibrosis.

Authors:  Ngoc Pham; Michelle S Ludwig; Min Wang; Afshin Ebrahimpour; Mark D Bonnen; Abdul Hafeez Diwan; Soo Jung Kim; Jason Bryan; Jared M Newton; Andrew G Sikora; Donald T Donovan; Vlad Sandulache; Yohannes T Ghebre
Journal:  Radiat Res       Date:  2019-08-15       Impact factor: 2.841

3.  Uroprotective effect of pantoprazole against cyclophosphamide-induced cystitis in mice.

Authors:  Seckin Engin; Elif Nur Barut; Burak Barut; Mine Kadioglu Duman; Cansu Kaya; Gokcen Kerimoglu; Arzu Ozel
Journal:  Support Care Cancer       Date:  2019-03-14       Impact factor: 3.603

4.  Eosinophilic esophagitis: interactions with gastroesophageal reflux disease.

Authors:  Edaire Cheng; Rhonda F Souza; Stuart Jon Spechler
Journal:  Gastroenterol Clin North Am       Date:  2014-03-24       Impact factor: 3.806

5.  Effects of pantoprazole on ulcer healing delay associated with NSAID treatment.

Authors:  Matteo Fornai; Rocchina Colucci; Luca Antonioli; Narcisa Ghisu; Marco Tuccori; Corrado Blandizzi; Mario Del Tacca
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-14       Impact factor: 3.000

Review 6.  Proton pump inhibitors for eosinophilic oesophagitis.

Authors:  Edaire Cheng
Journal:  Curr Opin Gastroenterol       Date:  2013-07       Impact factor: 3.287

Review 7.  Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications.

Authors:  Ramalinga R Kedika; Rhonda F Souza; Stuart Jon Spechler
Journal:  Dig Dis Sci       Date:  2009-11       Impact factor: 3.199

8.  Proton pump inhibitors are not the key for therapying non-steroidal anti-inflammatory drugs-induced small intestinal injury.

Authors:  Shuo Zhang; Guan-qun Chao; Bin Lu
Journal:  Rheumatol Int       Date:  2013-04-19       Impact factor: 2.631

9.  Effects of esomeprazole on glutathione levels and mitochondrial oxidative phosphorylation in the gastric mucosa of rats treated with indomethacin.

Authors:  O Pastoris; M Verri; F Boschi; O Kastsiuchenka; B Balestra; F Pace; M Tonini; G Natale
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-11       Impact factor: 3.000

Review 10.  Do proton pump inhibitors protect against cancer progression in GERD?

Authors:  Tomoharu Miyashita; Furhawn A Shah; John W Harmon; Guy P Marti; Daisuke Matsui; Koichi Okamoto; Isamu Makino; Hironori Hayashi; Katsunobu Oyama; Hisatoshi Nakagawara; Hidehiro Tajima; Hideto Fujita; Hiroyuki Takamura; Manabu Murakami; Itasu Ninomiya; Hirohisa Kitagawa; Sachio Fushida; Takashi Fujimura; Tetsuo Ohta
Journal:  Surg Today       Date:  2012-10-31       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.